Loading stock data…
Solventum Corporation (SOLV)
$78.01+0.77 (+1.00%)
Market ClosedLast close Jul 24
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Solventum Corporation in the Healthcare sector is trading at $78.01 with a market capitalization of $13.2B. Wall Street consensus targets $83.38 (13 analysts), implying a +6.9% move over the next 12 months. The stock is currently 12% below its 52-week high of $88.20, remaining 4.1% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +6.9% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.01B↑ | $2.00B↓ | $2.10B↓ | $2.16B↑ | $2.07B |
| Gross Profit | $1.09B↑ | $1.03B↓ | $1.14B↓ | $1.18B↑ | $1.11B |
| Operating Income | $79.00M↓ | $93.00M↓ | $172.00M↓ | $214.00M↑ | $152.00M |
| Net Income | $13.00M↓ | $63.00M↓ | $1.27B↑ | $90.00M↓ | $137.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Den...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$13.19B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
28.81%
Volume
Today's trading volume
488,083
Recent News
3 Reasons SOLV is Risky and 1 Stock to Buy Instead
Since January 2026, Solventum has been in a holding pattern, posting a small loss of 2.2% while floating around $77.29. The stock also fell short of the S&P 500’s 7.9% gain during that period.
Here's Why You Should Hold Solventum Stock in Your Portfolio for Now
SOLV's innovation, cost savings and strong segment demand support growth, while raw material cost increases remain a key risk.
Solventum’s Q2 2026 Earnings: What to Expect
Solventum is scheduled to report its fiscal second-quarter results early next month, with analysts expecting a modest year-over-year increase in earnings.
3M investors are still waiting for a more 'consistent' growth story
3M (MMM) stock is jumping on Tuesday after the manufacturer raised its full-year guidance. This comes amid 3M's turnaround plan, where the company has turned its attention toward simultaneously simplifying operations and boosting innovations. CFRA Research analyst Jonathan Sakraida highlights what this could all mean for the company, especially as it transitions into gaining more exposure to AI data centers.
2 S&P 500 Stocks to Own for Decades and 1 We Question
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.